Look for:

Our offer for

AMGEN INC.


ISIN:
US0311621009
WKN:
031162100

2021/02/26 22:00:00
Price
224.92 USD
Difference -1.14% (-2.60)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)108,216 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)224.40 USD (200)
Ask (Ask size)226.99 USD (100)
Open230.3134 USD
High230.3134 USD
Low223.615 USD
Close (prev. day)227.52 USD
VWAP225.068102 USD
Volume (pcs)3,453,451
Trading volume777,294,231.11
Number of trades51,401
Last size586,027

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: AMGEN INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/02/26 22:00:00
Price
224.92 USD
Difference -1.14% (-2.60)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)108,216 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)224.40 USD (200)
Ask (Ask size)226.99 USD (100)
Open230.3134 USD
High230.3134 USD
Low223.615 USD
Close (prev. day)227.52 USD
VWAP225.068102 USD
Volume (pcs)3,453,451
Trading volume777,294,231.11
Number of trades51,401
Last size586,027

Performance and Risk

6m1Y3Y
Perf (%)-8.34%+8.15%+21.88%
Perf (abs.)-20.70+17.14+40.85
Beta0.830.770.80
Volatility25.3137.7428.42
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)230.63 USD (2,637,054)
Ø price 30 days | Ø volume 30 days (pcs.)240.59 USD (2,511,287)
Ø price 100 days | Ø volume 100 days (pcs.)233.52 USD (2,548,380)
Ø price 250 days | Ø volume 250 days (pcs.)233.03 USD (2,807,597)
YTD High | date276.69 USD (2021/01/28)
YTD Low | date223.67 USD (2021/01/04)
52 Weeks High | date276.69 USD (2021/01/28)
52 Weeks Low | date177.05 USD (2020/03/23)

All listings for AMGEN INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/02/2617:35185.44 EUR0.2582
Vienna Stock Exchange2021/02/2617:32185.42 EUR0.0411
Tradegate2021/02/2622:26186.30 EUR0.4158
Stuttgart2021/02/2619:28186.28 EUR0.026
SIX Swiss Exchange2019/06/2717:35184.90 CHF0.002
Nasdaq2021/02/2622:00224.92 USD777.2951,400
Munich2021/02/2609:24187.36 EUR0.042
London Stock Exchange2021/02/2617:35223.975 USD0.004
Hong Kong Stock Exchange2021/02/1102:201,761.00 HKD--
Hanover2021/02/2608:04186.54 EUR0.002
Hamburg2021/02/2616:29184.94 EUR0.002
Frankfurt2021/02/2616:30185.00 EUR0.044
Duesseldorf2021/02/2619:31186.10 EUR0.0016
Borsa Italiana MTF Trading After Hours2021/01/1218:12194.86 EUR0.001
Borsa Italiana MTF Global Equity Market2021/02/2617:35184.92 EUR0.025
Berlin2021/02/2608:08186.12 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1823&ID_TYPE_IMAGE_LOGO=2

Contact Details

AMGEN INC.
- -
One Amgen Center Drive - 91320-1799 Thousand Oaks, CA
Telefon: +1-805-447-1000
Fax: +1-805-447-1010
E-mail: investor.relations@amgen.com

PDF Downloads

Company report: AMGEN INC.PDF Download

Company Profile

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Members of Management Board

Robert A. BradwayChairman of Board of Directors
Wanda M. AustinMember of Board of Directors
Tyler JacksMember of Board of Directors
Ronald D. SugarMember of Board of Directors
Robert A. EckertMember of Board of Directors
R. Sanders WilliamsMember of Board of Directors
Greg C. GarlandMember of Board of Directors
Fred HassanMember of Board of Directors
Ellen J. KullmanMember of Board of Directors
Charles M. Holley Jr.Member of Board of Directors
Brian J. DrukerMember of Board of Directors
Amy E. MilesMember of Board of Directors
Robert BradwayChairman of Managing Board
Victoria H. BlatterMember of Executive Committee
Tia BushMember of Executive Committee
Susan SweeneyMember of Executive Committee
Steven K. GalsonMember of Executive Committee
Rob LenzMember of Executive Committee
Raymond DeshaiesMember of Executive Committee
Peter H. GriffithMember of Executive Committee
Nancy GrygielMember of Executive Committee
Murdo GordonMember of Executive Committee
Mike ZahigianMember of Executive Committee
Mike NohaileMember of Executive Committee
Lori JohnstonMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer